| Cas No.: | 1260907-17-2 |
| 名称: | (S)-2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide |
| 别名: | I-BET-762,GSK525762,GSK-525762,GSK 525762 |
| SMILES: | N12C(C)=NN=C1[C@@H](CC(NCC)=O)N=C(C1=CC=C(Cl)C=C1)C1=CC(OC)=CC=C12 |
| 分子式: | C22H22ClN5O2 |
| 分子量: | 423.9 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | GSK525762 is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins with potential antineoplastic activity. Upon administration, the BET inhibitor GSK525762 binds to the acetylated lysine recogniti |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
